KEAP1 and chronic kidney disease: Apoptosis is a factor that promotes vascular calcification in patients with chronic kidney disease (CKD), and MitoQ inhibits vascular calcification by suppressing apoptosis of vascular smooth muscle cells (VSMC) via the Keap1/Nrf2 pathway (Cui et al., 2020).